Clinical Trial Update: Clazakizumab vs. Placebo - COVID-19 Infection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing clazakizumab to placebo in COVID-19 infection; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Infection

Drugs mentioned

• Clazakizumab (clazakizumab)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: COVID-19 Infection | Phase 2 | Status: UNKNOWN